Stockreport

What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday? [Yahoo! Finance]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF to resolve SEC charges over misleading statements related to a Phase 2 trial of the company's controversial Alzheimer's drug, simufilam The SEC also charged Hoau-Yan W [Read more]